Table 1.
Coding | Model coefficients | OR for effect of sex | ORs for effect of SNP, given sex | Prevalence | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sex | # Copies of effect allele | βsex | βSNP | ORsex (eβ sex) | ORSNP|M (e2βSNP) | ORSNP|W1 (eβSNP) | ORSNP|W2 (e2βSNP) | Overall | Female | Male | ||
(a) XCI (Clayton) coding | ||||||||||||
0 | 1 | 2 | 0 | 0.75 | e0 | e1.5 | e0.75 | e1.5 | 0.664 | 0.668 | 0.660 | |
M | 0 | 2 | NA | 0.1 | 0.5 | e0.1 | e1 | e0.5 | e1 | 0.628 | 0.618 | 0.638 |
F | 0 | 1 | 2 | 0.2 | 0.2 | e0.2 | e0.4 | e0.2 | e0.4 | 0.574 | 0.550 | 0.598 |
0.5 | 0.1 | e0.5 | e0.2 | e0.1 | e0.2 | 0.585 | 0.514 | 0.646 | ||||
0.75 | 0 | e0.75 | e0 | e0 | e0 | 0.589 | 0.500 | 0.678 | ||||
(b) eXCI (PLINK) coding | ||||||||||||
0 | 1 | 2 | 0 | 0.75 | e0 | e0.75 | e0.75 | e1.5 | 0.629 | 0.668 | 0.590 | |
M | 0 | 1 | NA | 0.1 | 0.5 | e0.1 | e0.5 | e0.5 | e1 | 0.602 | 0.618 | 0.586 |
F | 0 | 1 | 2 | 0.2 | 0.2 | e0.2 | e0.2 | e0.2 | e0.4 | 0.562 | 0.550 | 0.574 |
0.5 | 0.1 | e0.5 | e0.1 | e0.1 | e0.2 | 0.579 | 0.524 | 0.634 | ||||
0.75 | 0 | e0.75 | e0 | e0 | e0 | 0.589 | 0.500 | 0.678 |
Note: With the coding scheme used when generating the data specified on the left, we give how SNPs are coded within sex under each coding scheme. The “Model” column provides the five coefficient combinations we used to generate the data in this simulation study. We then calculated the odds ratio for the effect of sex and for the effect of SNP given sex. ORsex refers to the odds ratio for the effect of sex with female as the reference level and male equal to 1. ORSNP|M refers to the odds ratio for the effect of SNP, either comparing SNP = 0 with SNP = 2 in XCI (Clayton) or with SNP = 1 in eXCI (PLINK) coding, given sex = male. ORSNP|W1 refers to the odds ratio for the effect of SNP comparing SNP = 0 with SNP = 1 and ORSNP|W2 refers to the odds ratio for the effect of SNP comparing SNP = 0 with SNP = 2, given sex = female. In the “Prevalence” column, we calculated the proportion of cases in the overall population (1000 cases), in females (500 cases), and in males (500 cases).